Group a rotavirus and norovirus genotypes circulating in the northeastern Brazil in the post-monovalent vaccination era
Related Experiment Video
Updated: Apr 12, 2026

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
Published on: July 22, 2012
Ana Caroline C Sá1, Mariela M Gómez1, Ila Fernanda N Lima2
1Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute- Fiocruz, Rio de Janeiro, Brazil.
Insights
Group A rotavirus (RVA) and norovirus (NoV) infections are common in Brazilian children. Post-vaccination surveillance identified circulating G2P[4] RVA strains and diverse NoV genotypes, highlighting the need for ongoing monitoring.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Group A rotaviruses (RVA) and noroviruses (NoV) are primary causes of acute gastroenteritis (AGE) globally.
- Introduction of the monovalent (G1P[8]) rotavirus vaccine in Brazil in 2006 has coincided with reduced childhood diarrhea mortality and hospitalizations.
Purpose of the Study:
- To investigate the epidemiological profile of NoV and RVA infections in children with AGE in Northeastern Brazil.
- To characterize circulating RVA and NoV strains in the post-vaccine era.
Main Methods:
- Fecal samples from 200 children (≤10 years) in Fortaleza, Ceará (2008-2009) were screened for RVA and NoV.
- Positive samples underwent genotyping and sequencing for phylogenetic analysis.
Main Results:
- RVA prevalence was 12%, with all strains identified as G2P[4] genotype. Phylogenetic analysis indicated a DS-1-like constellation.
- NoV prevalence was 17%, with detected genotypes including GII.4 (59%), GII.12 (17%), GII.6 (9%), GII.3 (6%), and GII.? (9%).
- At least four NoV genotypes and two RVA G2P[4] variants were identified, suggesting reassortment events in RVA strains.
Conclusions:
- The study identified diverse circulating NoV genotypes and specific RVA G2P[4] variants in Northeastern Brazil.
- Findings underscore the importance of continuous surveillance for emerging RVA and NoV strains to assess their impact on AGE and vaccine effectiveness.
Abstract:
Group A rotaviruses (RVA) and noroviruses (NoV) are the leading cause of acute gastroenteritis (AGE) worldwide. Childhood diarrhea deaths and hospital admissions have declined since the introduction of the monovalent (G1P[8]) vaccine (Rotarix(®) [RV1]) in the National Immunization Program in Brazil in 2006. This study aims to investigate the epidemiological profile of NoV and RVA infections from children with AGE in the Northeastern region of Brazil in the post vaccine season. Two-hundred fecal samples collected from children up to 10 years old in Fortaleza, Ceará between 2008-2009 were screened for the presence of RVA and NoV. Positive samples were genotyped and sequenced. The RVA screening revealed 12% prevalence and all RVA strains belonged to G2P[4] genotype. Phylogenetic analysis based on the 11 RVA genome segments sequenced from eight samples revealed a DS-1-like genotype constellation: I2-R2-C2-M2-A2-N2-T2-E2-H2. For NoV screening, the prevalence observed was 17% and the following genotypes were detected: GII.4 (59%), GII.12 (17%), GII.6 (9%), GII.3 (6%), and GII.? (9%). At least four different NoVs genotypes and two RVA G2P[4] variants were identified circulating in the Northeastern region of Brazil. RVA phylogenetic analysis suggests that the RVA G2P[4] strains might have originated from intragenogroup reassortment events. Whether the genetic modifications observed in these contemporary G2P[4] RVA strains may impact the long-term effectiveness of the current vaccination programs remains to be explored. These data reinforce the importance of surveillance for monitoring the emergence of new strains of RVA and NoV and their impact on cases of acute gastroenteritis.
Related Concept Videos
Bacterial Gastroenteritis
Vaccinations
Arboviral Encephalitis
Infectious Diseases and Their Occurrence
Cholera
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

